SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-005271
Filing Date
2024-01-19
Accepted
2024-01-19 17:03:44
Documents
12
Period of Report
2024-01-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm243558d1_8k.htm   iXBRL 8-K 26597
  Complete submission text file 0001104659-24-005271.txt   200918

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20240115.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20240115_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20240115_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT tm243558d1_8k_htm.xml XML 3428
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40498 | Film No.: 24546356
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)